CATEGORY

e-COA

Electronic patient forms expected to disrupt the paper based forms market.

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike e-COA.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    e-COA Suppliers


    e-COA Supplier

    Find the right-fit e-coa supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    IQVIA HOLDINGS INC.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    4
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    36

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    41
    Social
    30
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    48
    Human rights
    39
    Community Environment
    31
    Corporate governance
    40
    Human resources
    22
    Security Scorecard
    77

    Threat indicators
    C
    75
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    D
    63
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    C
    70
    Application Security
    Detecting common website application vulnerbilities
    C
    77
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    D
    60
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    100
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    iqvia.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    1
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    1
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    2
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    2
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    28
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    e-COA market report transcript


    Global Market Outlook on e-COA

    e-COA has been a long discussed topic, but the adoption rate has been really slow owing to various factors including regulations not being lined properly. This is expected to change in the coming years, with more than 20–25% of overall trials expected to incorporate e-COA solutions.

    e-coa marketE-COA is expected to be the most attractive type of solution in the global e-PRO, e-COA and e-Patient Diaries market. The need for improving safety for patients in clinical trial is the main reason for the growth of this market, with the digital trials picking up pace.

    • eCOA segment is expected to grow at an increased rate, contributing to 66 percent of the ePRO, eCOA and e-Patient Diaries market
    • Close to 15 percent of the trials are integrated with e-COA solutions and is expected to rise by almost 20 percent by 2018
    • It is noticed that there is a change in the preference moving from a web-based system to a cloud –based system owing to the benefits involved
    • Owing to ease of operations and availability of infrastructure, web-based solutions are dominating the market. However, cloud based systems are expected to grow at a faster pace mainly due to the benefits involved

    Cost –effective development means, easy installation, maintenance and customization are the major reason for predominance of web-based solutions. However, with the rise in the shift to cloud systems, will open up opportunities for such solutions.

    Cloud adoption among pharma has observed a growth of approximately 20 percent over a period of 6 years.

    Market /Technology Trends

    With the industry relying upon technology to a greater extent, suppliers in the industry are advancing with ideas to make trial process and experience better.

    The next wave of BYOD (in E-COA) that manages to support research, in terms of data collection from verbal computer interfaces and wearable/external devices is critical.

    BYOD Devices

    • Currently adoption is more in post-approval research. With the regulatory bodies promoting remote trials and e-tools to collect patient data, there will be an increasing growth
    • BYOD 2.0 devices are being explored in phase III trials is also observed
    • E.g. CRF health was chosen by an European Pharma to perform Phase III Insomnia trial

    Number of CROs and Sponsors

    • Continuous evolution of various technologies in the life science industry, there is an increasing demand for clinical trial technologies in healthcare centers and hospitals
    • Due to the advancements in clinical trial technologies, there is increase in the number of sponsors and CROs in healthcare

    Usage of Smart Devices

    • With the advancements in technology, smartphone applications being offered for easy monitoring and analyzing the patient data that is tracked is one of the prominent features of using smartphones in clinical outcome assessment
    • Also with the increase in use of smart and mobile devices across globe, the demand for e-PRO and e-COA is increasing in the market